Association Between Shortened Leukocyte Telomere Length and Cardiometabolic Outcomes: Systematic Review and Meta-Analysis
BACKGROUND—Telomeres are repetitive, gene-poor regions that cap the ends of DNA and help maintain chromosomal integrity. Their shortening is caused by inflammation and oxidative stress within the cellular environment and ultimately leads to cellular senescence. Shortened leukocyte telomere length is...
Saved in:
Published in | Circulation. Cardiovascular genetics Vol. 8; no. 1; pp. 82 - 90 |
---|---|
Main Authors | , , , , , |
Format | Journal Article |
Language | English |
Published |
United States
American Heart Association, Inc
01.02.2015
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | BACKGROUND—Telomeres are repetitive, gene-poor regions that cap the ends of DNA and help maintain chromosomal integrity. Their shortening is caused by inflammation and oxidative stress within the cellular environment and ultimately leads to cellular senescence. Shortened leukocyte telomere length is hypothesized to be a novel biomarker for age and age-related diseases, yet reports on its association with cardiometabolic outcomes in the literature are conflicting.
METHODS AND RESULTS—MEDLINE (1966 to present) and EMBASE (1980 to present) were last searched on September 9, 2013. Reference lists of retrieved citations were hand searched for relevant studies. No restrictions were placed on sample size, language, or publication type or date. Fifteen cohort and 12 case–control studies reporting the association between leukocyte telomere length and stroke, myocardial infarction, and type 2 diabetes mellitus were independently selected for inclusion by 2 reviewers. Data extraction and risk of bias assessment were completed independently by 2 reviewers using predefined criteria. Studies were pooled using the generic inverse variance method and both fixed and random effects models. A 1-SD decrease in leukocyte telomere length was significantly associated with stroke (odds ratio, 1.21; 95% confidence interval, 1.06–1.37; I=61%), myocardial infarction (odds ratio, 1.24; 95% confidence interval, 1.04–1.47; I=68%), and type 2 diabetes mellitus (odds ratio, 1.37; 95% confidence interval, 1.10–1.72; I=91%). Stratification by measurement technique, study design, study size, and ethnicity explained heterogeneity in certain cardiometabolic outcomes.
CONCLUSIONS—Shortened leukocyte telomere length demonstrates a significant association with stroke, myocardial infarction, and type 2 diabetes mellitus. Larger, well-designed studies are needed to confirm these findings and explore sources of heterogeneity. |
---|---|
AbstractList | BACKGROUND—Telomeres are repetitive, gene-poor regions that cap the ends of DNA and help maintain chromosomal integrity. Their shortening is caused by inflammation and oxidative stress within the cellular environment and ultimately leads to cellular senescence. Shortened leukocyte telomere length is hypothesized to be a novel biomarker for age and age-related diseases, yet reports on its association with cardiometabolic outcomes in the literature are conflicting.
METHODS AND RESULTS—MEDLINE (1966 to present) and EMBASE (1980 to present) were last searched on September 9, 2013. Reference lists of retrieved citations were hand searched for relevant studies. No restrictions were placed on sample size, language, or publication type or date. Fifteen cohort and 12 case–control studies reporting the association between leukocyte telomere length and stroke, myocardial infarction, and type 2 diabetes mellitus were independently selected for inclusion by 2 reviewers. Data extraction and risk of bias assessment were completed independently by 2 reviewers using predefined criteria. Studies were pooled using the generic inverse variance method and both fixed and random effects models. A 1-SD decrease in leukocyte telomere length was significantly associated with stroke (odds ratio, 1.21; 95% confidence interval, 1.06–1.37; I=61%), myocardial infarction (odds ratio, 1.24; 95% confidence interval, 1.04–1.47; I=68%), and type 2 diabetes mellitus (odds ratio, 1.37; 95% confidence interval, 1.10–1.72; I=91%). Stratification by measurement technique, study design, study size, and ethnicity explained heterogeneity in certain cardiometabolic outcomes.
CONCLUSIONS—Shortened leukocyte telomere length demonstrates a significant association with stroke, myocardial infarction, and type 2 diabetes mellitus. Larger, well-designed studies are needed to confirm these findings and explore sources of heterogeneity. Telomeres are repetitive, gene-poor regions that cap the ends of DNA and help maintain chromosomal integrity. Their shortening is caused by inflammation and oxidative stress within the cellular environment and ultimately leads to cellular senescence. Shortened leukocyte telomere length is hypothesized to be a novel biomarker for age and age-related diseases, yet reports on its association with cardiometabolic outcomes in the literature are conflicting. MEDLINE (1966 to present) and EMBASE (1980 to present) were last searched on September 9, 2013. Reference lists of retrieved citations were hand searched for relevant studies. No restrictions were placed on sample size, language, or publication type or date. Fifteen cohort and 12 case-control studies reporting the association between leukocyte telomere length and stroke, myocardial infarction, and type 2 diabetes mellitus were independently selected for inclusion by 2 reviewers. Data extraction and risk of bias assessment were completed independently by 2 reviewers using predefined criteria. Studies were pooled using the generic inverse variance method and both fixed and random effects models. A 1-SD decrease in leukocyte telomere length was significantly associated with stroke (odds ratio, 1.21; 95% confidence interval, 1.06-1.37; I(2)=61%), myocardial infarction (odds ratio, 1.24; 95% confidence interval, 1.04-1.47; I(2)=68%), and type 2 diabetes mellitus (odds ratio, 1.37; 95% confidence interval, 1.10-1.72; I(2)=91%). Stratification by measurement technique, study design, study size, and ethnicity explained heterogeneity in certain cardiometabolic outcomes. Shortened leukocyte telomere length demonstrates a significant association with stroke, myocardial infarction, and type 2 diabetes mellitus. Larger, well-designed studies are needed to confirm these findings and explore sources of heterogeneity. Telomeres are repetitive, gene-poor regions that cap the ends of DNA and help maintain chromosomal integrity. Their shortening is caused by inflammation and oxidative stress within the cellular environment and ultimately leads to cellular senescence. Shortened leukocyte telomere length is hypothesized to be a novel biomarker for age and age-related diseases, yet reports on its association with cardiometabolic outcomes in the literature are conflicting.BACKGROUNDTelomeres are repetitive, gene-poor regions that cap the ends of DNA and help maintain chromosomal integrity. Their shortening is caused by inflammation and oxidative stress within the cellular environment and ultimately leads to cellular senescence. Shortened leukocyte telomere length is hypothesized to be a novel biomarker for age and age-related diseases, yet reports on its association with cardiometabolic outcomes in the literature are conflicting.MEDLINE (1966 to present) and EMBASE (1980 to present) were last searched on September 9, 2013. Reference lists of retrieved citations were hand searched for relevant studies. No restrictions were placed on sample size, language, or publication type or date. Fifteen cohort and 12 case-control studies reporting the association between leukocyte telomere length and stroke, myocardial infarction, and type 2 diabetes mellitus were independently selected for inclusion by 2 reviewers. Data extraction and risk of bias assessment were completed independently by 2 reviewers using predefined criteria. Studies were pooled using the generic inverse variance method and both fixed and random effects models. A 1-SD decrease in leukocyte telomere length was significantly associated with stroke (odds ratio, 1.21; 95% confidence interval, 1.06-1.37; I(2)=61%), myocardial infarction (odds ratio, 1.24; 95% confidence interval, 1.04-1.47; I(2)=68%), and type 2 diabetes mellitus (odds ratio, 1.37; 95% confidence interval, 1.10-1.72; I(2)=91%). Stratification by measurement technique, study design, study size, and ethnicity explained heterogeneity in certain cardiometabolic outcomes.METHODS AND RESULTSMEDLINE (1966 to present) and EMBASE (1980 to present) were last searched on September 9, 2013. Reference lists of retrieved citations were hand searched for relevant studies. No restrictions were placed on sample size, language, or publication type or date. Fifteen cohort and 12 case-control studies reporting the association between leukocyte telomere length and stroke, myocardial infarction, and type 2 diabetes mellitus were independently selected for inclusion by 2 reviewers. Data extraction and risk of bias assessment were completed independently by 2 reviewers using predefined criteria. Studies were pooled using the generic inverse variance method and both fixed and random effects models. A 1-SD decrease in leukocyte telomere length was significantly associated with stroke (odds ratio, 1.21; 95% confidence interval, 1.06-1.37; I(2)=61%), myocardial infarction (odds ratio, 1.24; 95% confidence interval, 1.04-1.47; I(2)=68%), and type 2 diabetes mellitus (odds ratio, 1.37; 95% confidence interval, 1.10-1.72; I(2)=91%). Stratification by measurement technique, study design, study size, and ethnicity explained heterogeneity in certain cardiometabolic outcomes.Shortened leukocyte telomere length demonstrates a significant association with stroke, myocardial infarction, and type 2 diabetes mellitus. Larger, well-designed studies are needed to confirm these findings and explore sources of heterogeneity.CONCLUSIONSShortened leukocyte telomere length demonstrates a significant association with stroke, myocardial infarction, and type 2 diabetes mellitus. Larger, well-designed studies are needed to confirm these findings and explore sources of heterogeneity. |
Author | Anand, Sonia S. Gerstein, Hertzel D’Mello, Matthew J.J. Briel, Matthias Paré, Guillaume Ross, Stephanie A. |
AuthorAffiliation | From the Population Health Research Institute, Hamilton Health Sciences, Hamilton, Ontario, Canada (M.J.J.D., S.A.R., S.S.A., H.G., G.P.); Basel Institute for Clinical Epidemiology and Biostatistics, University Hospital, Basel, Switzerland (M.B.); and Department of Clinical Epidemiology and Biostatistics (M.B., S.S.A., H.G., G.P.), Department of Medicine (S.S.A., H.G.), and Department of Pathology and Molecular Medicine (G.P.), McMaster University, Hamilton, Ontario, Canada |
AuthorAffiliation_xml | – name: From the Population Health Research Institute, Hamilton Health Sciences, Hamilton, Ontario, Canada (M.J.J.D., S.A.R., S.S.A., H.G., G.P.); Basel Institute for Clinical Epidemiology and Biostatistics, University Hospital, Basel, Switzerland (M.B.); and Department of Clinical Epidemiology and Biostatistics (M.B., S.S.A., H.G., G.P.), Department of Medicine (S.S.A., H.G.), and Department of Pathology and Molecular Medicine (G.P.), McMaster University, Hamilton, Ontario, Canada |
Author_xml | – sequence: 1 givenname: Matthew surname: D’Mello middlename: J.J. fullname: D’Mello, Matthew J.J. organization: From the Population Health Research Institute, Hamilton Health Sciences, Hamilton, Ontario, Canada (M.J.J.D., S.A.R., S.S.A., H.G., G.P.); Basel Institute for Clinical Epidemiology and Biostatistics, University Hospital, Basel, Switzerland (M.B.); and Department of Clinical Epidemiology and Biostatistics (M.B., S.S.A., H.G., G.P.), Department of Medicine (S.S.A., H.G.), and Department of Pathology and Molecular Medicine (G.P.), McMaster University, Hamilton, Ontario, Canada – sequence: 2 givenname: Stephanie surname: Ross middlename: A. fullname: Ross, Stephanie A. – sequence: 3 givenname: Matthias surname: Briel fullname: Briel, Matthias – sequence: 4 givenname: Sonia surname: Anand middlename: S. fullname: Anand, Sonia S. – sequence: 5 givenname: Hertzel surname: Gerstein fullname: Gerstein, Hertzel – sequence: 6 givenname: Guillaume surname: Paré fullname: Paré, Guillaume |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/25406241$$D View this record in MEDLINE/PubMed |
BookMark | eNqFkUtv1DAUhS1URB_0L0CWbFL8ysNILIZoWkYaqNQZpO4sx7lhTJ242E5H-feYTosQGxaW7aPv3Gufe4qORjcCQm8JviCkJO-b1U1ztfy63K6aTVLYBcaY18ULdEIEpzmjZX3051zcHqPTEH5gXHLGylfomBYcl5STEzQvQnDaqGjcmH2CuAcYs83O-QgjdNkapjun5wjZFqwbwEOSxu9xl6mxyxrlO5PUqFpnjc6up6jTNXzINnOIMKSqOruBBwP7R_5LIvPFqOwcTHiNXvbKBjh_2s_Qt8vltvmcr6-vVs1inWtW1CwXBETZqaLV6cEdAeiruuJ9XXW616JXhRYtFR1wSoUqaSt03aeP1nUlegZMszP07lD33rufE4QoBxM0WKtGcFOQpCyqlBcWIqFvntCpHaCT994Mys_yOa4EfDwA2rsQPPRSm_iYXfTKWEmw_D0e-fd4ksLkYTzJX_3jf27xfyc_OPfORvDhzk578HIHysadxISxiosqp5gUmCZPnlYSfwHHvab6 |
CitedBy_id | crossref_primary_10_1016_j_ekir_2017_12_005 crossref_primary_10_1038_mp_2017_48 crossref_primary_10_1177_1535370220931509 crossref_primary_10_1111_add_15312 crossref_primary_10_3389_fcell_2021_618335 crossref_primary_10_1016_j_hlc_2019_12_012 crossref_primary_10_1038_npp_2017_125 crossref_primary_10_1098_rstb_2016_0436 crossref_primary_10_1016_j_biopsycho_2019_03_013 crossref_primary_10_1016_j_psyneuen_2015_10_018 crossref_primary_10_1016_j_mad_2024_111929 crossref_primary_10_1186_s12967_020_02551_1 crossref_primary_10_1373_jalm_2016_022137 crossref_primary_10_1016_j_jacc_2016_03_541 crossref_primary_10_1007_s11262_023_02010_1 crossref_primary_10_1146_annurev_clinpsy_032816_045054 crossref_primary_10_1371_journal_pone_0293589 crossref_primary_10_3945_jn_116_234922 crossref_primary_10_3390_cancers17020257 crossref_primary_10_1111_cen_13918 crossref_primary_10_1098_rstb_2017_0151 crossref_primary_10_1161_ATVBAHA_115_305838 crossref_primary_10_1016_j_bbi_2016_02_002 crossref_primary_10_1016_j_jacc_2016_03_530 crossref_primary_10_1016_j_amjcard_2015_03_060 crossref_primary_10_1016_j_atherosclerosis_2019_03_010 crossref_primary_10_1016_j_biopsycho_2019_107809 crossref_primary_10_3390_jcm8040511 crossref_primary_10_3389_fcvm_2021_812363 crossref_primary_10_3390_ijms23158672 crossref_primary_10_1093_aje_kwv203 crossref_primary_10_3390_nu10121942 crossref_primary_10_1038_s41580_020_00314_w crossref_primary_10_17116_terarkh2017896102_109 crossref_primary_10_1016_j_numecd_2024_103830 crossref_primary_10_1002_JPER_20_0269 crossref_primary_10_1007_s12011_019_1656_3 crossref_primary_10_1016_j_bcmd_2021_102563 crossref_primary_10_1017_S2040174420000355 crossref_primary_10_1016_j_pcad_2017_04_001 crossref_primary_10_17352_jbm_000025 crossref_primary_10_1016_j_sleh_2019_12_003 crossref_primary_10_1038_s41598_020_66729_9 crossref_primary_10_18632_oncotarget_22509 crossref_primary_10_1016_j_cpnec_2021_100029 crossref_primary_10_1097_GME_0000000000000890 crossref_primary_10_3390_microorganisms11071818 crossref_primary_10_3390_ijms20215508 crossref_primary_10_15829_1728_8800_2022_3272 crossref_primary_10_1016_j_jpeds_2019_08_040 crossref_primary_10_1016_j_jab_2016_09_004 crossref_primary_10_14814_phy2_15910 crossref_primary_10_1016_j_psyneuen_2017_10_003 crossref_primary_10_1080_14659891_2023_2239345 crossref_primary_10_1038_s41598_020_79615_1 crossref_primary_10_1111_jdi_13470 crossref_primary_10_1038_s41598_018_36756_8 crossref_primary_10_1161_CIRCRESAHA_118_312567 crossref_primary_10_1111_hel_12760 crossref_primary_10_1161_CIRCRESAHA_117_311751 crossref_primary_10_1161_CIRCRESAHA_118_312202 crossref_primary_10_1186_s12877_019_1383_9 crossref_primary_10_1038_s41598_023_35912_z crossref_primary_10_1016_j_jacc_2016_01_061 crossref_primary_10_18632_aging_203849 crossref_primary_10_3390_ijerph18041848 crossref_primary_10_30629_2618_6667_2024_22_6_16_26 crossref_primary_10_3390_brainsci12020259 crossref_primary_10_1016_j_biopsycho_2022_108446 crossref_primary_10_1177_08982643251313923 crossref_primary_10_1002_jbmr_4261 crossref_primary_10_18632_aging_203285 crossref_primary_10_1016_j_jaad_2017_11_026 crossref_primary_10_1038_s41598_022_17246_4 crossref_primary_10_1016_j_jamda_2016_04_021 crossref_primary_10_1002_gps_5390 crossref_primary_10_1371_journal_pone_0133174 crossref_primary_10_1016_j_cjca_2021_10_012 crossref_primary_10_3389_fragi_2022_1044038 crossref_primary_10_3390_dna4020011 crossref_primary_10_1016_j_ebiom_2022_103978 crossref_primary_10_1016_j_neulet_2019_04_020 crossref_primary_10_1161_CIRCGENETICS_117_001718 crossref_primary_10_18632_aging_102627 crossref_primary_10_3390_cells10020395 crossref_primary_10_1016_j_arr_2021_101411 crossref_primary_10_2174_1568026620666200131125110 crossref_primary_10_3390_ijerph18179380 crossref_primary_10_4137_GRSB_S39836 crossref_primary_10_1007_s42764_024_00123_x crossref_primary_10_1016_j_exger_2018_06_027 crossref_primary_10_1155_2020_9256107 crossref_primary_10_12688_f1000research_14068_1 crossref_primary_10_3389_fnagi_2016_00300 crossref_primary_10_1016_j_atherosclerosis_2021_08_013 crossref_primary_10_3389_fendo_2018_00309 crossref_primary_10_1371_journal_pone_0195963 crossref_primary_10_3389_fendo_2021_650922 crossref_primary_10_3389_fgene_2017_00198 crossref_primary_10_1161_JAHA_116_004105 crossref_primary_10_3390_nu14235191 crossref_primary_10_1002_ajhb_23375 crossref_primary_10_1183_16000617_0041_2021 crossref_primary_10_1016_j_neubiorev_2017_11_002 crossref_primary_10_1016_j_trecan_2017_02_005 crossref_primary_10_1093_aje_kwae181 crossref_primary_10_1016_j_banm_2022_02_018 crossref_primary_10_1038_ejcn_2016_93 crossref_primary_10_1111_jth_13689 crossref_primary_10_3390_ijms18122573 crossref_primary_10_1098_rstb_2016_0441 crossref_primary_10_3390_biomedicines11123211 crossref_primary_10_18632_oncotarget_18167 crossref_primary_10_1016_j_copsyc_2018_11_009 crossref_primary_10_1113_JP273689 crossref_primary_10_34067_KID_0000000603 crossref_primary_10_1038_s41598_019_43387_0 crossref_primary_10_1093_ejendo_lvad015 crossref_primary_10_1016_j_kint_2020_02_034 crossref_primary_10_3390_nu15204373 crossref_primary_10_1016_j_neubiorev_2019_03_010 crossref_primary_10_3390_cells7110193 crossref_primary_10_1371_journal_pone_0237477 crossref_primary_10_3390_nu13082585 crossref_primary_10_1016_j_psyneuen_2018_10_019 crossref_primary_10_1093_eurjpc_zwaa115 crossref_primary_10_1007_s00125_020_05242_0 crossref_primary_10_1016_j_envres_2022_112810 crossref_primary_10_1016_j_jacc_2017_05_034 crossref_primary_10_1016_j_psyneuen_2016_02_007 crossref_primary_10_1016_j_psyneuen_2019_04_018 crossref_primary_10_1007_s11883_023_01082_6 crossref_primary_10_1093_gerona_glaa190 crossref_primary_10_1016_j_atherosclerosis_2017_09_016 crossref_primary_10_1186_s12933_022_01635_0 crossref_primary_10_1111_ijpo_12136 crossref_primary_10_1096_fj_201901275R crossref_primary_10_1002_em_21991 crossref_primary_10_3390_biomedicines9101335 crossref_primary_10_1016_j_jacbts_2018_07_004 crossref_primary_10_1161_HYPERTENSIONAHA_117_09354 crossref_primary_10_1038_s41598_021_90435_9 crossref_primary_10_1097_PSY_0000000000001220 crossref_primary_10_1016_j_envint_2021_106765 crossref_primary_10_1007_s11357_023_00914_2 crossref_primary_10_18632_aging_101216 crossref_primary_10_3389_fneur_2019_00624 crossref_primary_10_1016_j_psyneuen_2022_105876 crossref_primary_10_3390_genes7040015 crossref_primary_10_1111_1753_0407_13376 crossref_primary_10_1152_ajpheart_00197_2017 crossref_primary_10_1016_j_tice_2022_101925 crossref_primary_10_3389_fphys_2021_789690 crossref_primary_10_3390_ijerph18041743 crossref_primary_10_1007_s00592_022_02004_9 crossref_primary_10_1126_sciadv_aao1617 crossref_primary_10_1371_journal_pone_0160748 crossref_primary_10_3389_fgene_2017_00164 crossref_primary_10_1097_HCO_0000000000000613 crossref_primary_10_18087_cardio_2021_11_n1233 crossref_primary_10_3390_jcdd10120492 crossref_primary_10_1016_j_cjca_2016_02_002 crossref_primary_10_1186_s12888_019_2404_0 crossref_primary_10_1038_s41598_017_06036_y crossref_primary_10_1016_j_psyneuen_2022_105762 crossref_primary_10_3390_nu13020318 crossref_primary_10_1007_s00129_020_04623_1 crossref_primary_10_1038_s41598_020_61241_6 crossref_primary_10_1111_ggi_12738 crossref_primary_10_1177_0300060516667132 crossref_primary_10_1016_j_rmed_2019_05_009 crossref_primary_10_1016_j_psyneuen_2019_03_002 crossref_primary_10_1371_journal_pone_0268689 crossref_primary_10_1139_cjpp_2018_0582 crossref_primary_10_1161_CIRCRESAHA_117_310698 crossref_primary_10_3389_fcvm_2018_00018 crossref_primary_10_1097_PSY_0000000000000356 crossref_primary_10_1016_j_psychres_2021_113941 crossref_primary_10_1007_s10522_022_10011_0 crossref_primary_10_3945_ajcn_115_116806 crossref_primary_10_1177_0890117120906958 crossref_primary_10_1016_j_jpsychores_2022_110760 crossref_primary_10_3390_antiox12101847 crossref_primary_10_3390_nu14193885 crossref_primary_10_1096_fj_201700630r crossref_primary_10_1016_j_encep_2020_12_001 crossref_primary_10_1186_s13643_019_1199_x crossref_primary_10_1177_0300060519882570 crossref_primary_10_1016_j_socscimed_2016_03_029 crossref_primary_10_3390_genes7090058 crossref_primary_10_1016_j_psyneuen_2019_03_012 crossref_primary_10_1016_j_psyneuen_2016_09_006 crossref_primary_10_1093_fampra_cmad064 crossref_primary_10_3390_ijms20123032 crossref_primary_10_3390_ijms22189867 crossref_primary_10_1186_s12916_022_02620_w crossref_primary_10_1007_s00592_016_0857_x crossref_primary_10_1016_j_physbeh_2018_11_011 crossref_primary_10_1253_circj_CJ_19_0446 crossref_primary_10_3390_ijms252413671 crossref_primary_10_1186_s12940_021_00778_z crossref_primary_10_3390_cells9061360 crossref_primary_10_1371_journal_pgen_1006144 crossref_primary_10_1017_S2040174424000291 crossref_primary_10_1016_j_ihj_2018_09_007 crossref_primary_10_1016_j_neubiorev_2022_104526 crossref_primary_10_1371_journal_pone_0180687 crossref_primary_10_1016_j_jacc_2021_05_011 crossref_primary_10_14336_AD_2019_0721 crossref_primary_10_1016_j_annepidem_2019_12_009 crossref_primary_10_1016_j_arr_2019_02_003 crossref_primary_10_1080_10615806_2016_1261286 crossref_primary_10_1016_j_rccar_2019_11_001 crossref_primary_10_1161_CIRCGENETICS_114_000964 crossref_primary_10_3390_cells8050381 crossref_primary_10_3390_biom12010039 crossref_primary_10_14336_AD_2023_0115 crossref_primary_10_1007_s11033_024_10077_8 crossref_primary_10_1093_gerona_glab193 crossref_primary_10_1080_10408398_2021_1952402 crossref_primary_10_3390_nu16172963 crossref_primary_10_7759_cureus_10794 crossref_primary_10_3917_heg_123_0269 crossref_primary_10_1161_JAHA_120_020606 crossref_primary_10_1186_s13104_017_2791_6 crossref_primary_10_1016_j_socscimed_2024_117229 crossref_primary_10_1097_PSY_0000000000000383 crossref_primary_10_1097_JOM_0000000000001102 crossref_primary_10_1093_jnci_djy189 crossref_primary_10_2196_45535 crossref_primary_10_1016_j_bbii_2023_100023 crossref_primary_10_1038_s41467_025_57794_7 crossref_primary_10_1080_09553002_2021_1956010 crossref_primary_10_1038_tp_2016_164 crossref_primary_10_1093_aje_kwy124 crossref_primary_10_1177_1747493018772800 crossref_primary_10_1080_15384101_2020_1728016 crossref_primary_10_1093_mutage_gey015 crossref_primary_10_1089_chi_2017_0159 crossref_primary_10_7717_peerj_15085 crossref_primary_10_1016_j_mrrev_2020_108309 crossref_primary_10_1136_heartjnl_2019_315629 crossref_primary_10_18632_aging_103459 crossref_primary_10_1136_heartjnl_2020_318654 crossref_primary_10_1161_CIRCRESAHA_116_310517 crossref_primary_10_26416_Med_158_2_2024_9543 crossref_primary_10_1097_MCO_0000000000000477 crossref_primary_10_1002_mef2_50 |
Cites_doi | 10.1371/journal.pone.0034948 10.1016/S0140-6736(03)12384-7 10.1038/sj.onc.1202797 10.1016/j.cca.2009.02.004 10.1161/01.RES.0000233315.38086.bc 10.1007/s00125-002-1009-0 10.1161/ATVBAHA.110.205492 10.1006/excr.1995.1213 10.1210/jc.2011-1562 10.1093/aje/kwj346 10.1016/j.mrfmmm.2011.04.003 10.2337/db12-0241 10.2337/db13-0744 10.1161/HYPERTENSIONAHA.108.123752 10.1093/gerona/glp061 10.1073/pnas.85.18.6622 10.1093/gerona/glq224 10.2337/diab.44.4.369 10.1371/journal.pone.0019687 10.1097/00004647-200102000-00001 10.1146/annurev.physiol.010908.163111 10.1016/S0140-6736(06)68967-8 10.1016/j.atherosclerosis.2009.09.070 10.1007/s11010-012-1276-0 10.1016/j.atherosclerosis.2009.03.034 10.1038/345458a0 10.1038/ncomms2602 10.1111/ene.12135 10.1042/CS20120691 10.1111/j.1474-9726.2005.00171.x 10.1038/ng.2528 10.1016/S0014-5793(99)00748-6 10.1089/rej.2009.0975 10.2174/092986707779313381 10.1161/01.ATV.0000067426.96344.32 10.1093/epirev/mxs008 10.1161/STROKEAHA.111.637207 10.1038/jhh.2011.57 10.1016/j.trsl.2009.09.012 10.1371/journal.pone.0068254 10.1001/jama.1979.03290450033020 10.1111/j.1474-9726.2009.00470.x 10.1093/gerona/glq164 10.1161/ATVBAHA.111.237271 10.1161/ATVBAHA.110.217158 |
ContentType | Journal Article |
Copyright | 2015 American Heart Association, Inc. 2014 American Heart Association, Inc. |
Copyright_xml | – notice: 2015 American Heart Association, Inc. – notice: 2014 American Heart Association, Inc. |
DBID | AAYXX CITATION CGR CUY CVF ECM EIF NPM 7X8 |
DOI | 10.1161/CIRCGENETICS.113.000485 |
DatabaseName | CrossRef Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed MEDLINE - Academic |
DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) MEDLINE - Academic |
DatabaseTitleList | MEDLINE MEDLINE - Academic |
Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine |
EISSN | 1942-3268 |
EndPage | 90 |
ExternalDocumentID | 25406241 10_1161_CIRCGENETICS_113_000485 01337497-201502000-00013 |
Genre | Meta-Analysis Systematic Review Journal Article |
GroupedDBID | --- .XZ .Z2 29B 53G 5GY 5VS AAAAV AAHPQ AAIQE AAJCS AARTV AASCR ABASU ABBUW ABDIG ABJNI ABVCZ ABXVJ ABXYN ABZAD ABZZY ACDDN ACEWG ACGFS ACILI ACPRK ACWDW ACWRI ACXJB ACXNZ ADBBV ADGGA ADHPY ADNKB AEBDS AEETU AFBFQ AFDTB AFEXH AFNMH AFUWQ AHQNM AHQVU AHRYX AHVBC AINUH AJCLO AJIOK AJNWD AJNYG AJZMW AKCTQ ALKUP ALMA_UNASSIGNED_HOLDINGS ALMTX AMJPA AMKUR AMNEI AOHHW AOQMC BAWUL BQLVK C45 DIK DIWNM DUNZO E.X E3Z EBS EEVPB EJD EX3 F5P FCALG FL- GNXGY GQDEL H13 HLJTE HZ~ IKREB IN~ IPNFZ KD2 KQ8 KQB L-C O9- ODMTH ODZKP OHYEH OPUJH OUVQU OVD OVDNE OXXIT P2P P6G RAH RIG S4S TEORI TR2 TSPGW V2I W2D W3M W8F WOW ZZMQN AAYXX CITATION CGR CUY CVF ECM EIF NPM 7X8 |
ID | FETCH-LOGICAL-c3583-91e96da5bc624d1eef7874f87dcfc9fa5c9b29de4229a62b9c8f0068879f3e3c3 |
ISSN | 1942-325X 1942-3268 |
IngestDate | Thu Jul 10 21:56:24 EDT 2025 Sun Jul 13 01:33:33 EDT 2025 Tue Jul 01 02:20:31 EDT 2025 Thu Apr 24 23:09:12 EDT 2025 Fri May 16 03:43:26 EDT 2025 |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 1 |
Keywords | diabetes mellitus, type 2 aging stroke myocardial infarction |
Language | English |
License | 2014 American Heart Association, Inc. |
LinkModel | OpenURL |
MergedId | FETCHMERGED-LOGICAL-c3583-91e96da5bc624d1eef7874f87dcfc9fa5c9b29de4229a62b9c8f0068879f3e3c3 |
Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 ObjectType-Review-3 content type line 23 ObjectType-Undefined-4 |
PMID | 25406241 |
PQID | 1657326099 |
PQPubID | 23479 |
PageCount | 9 |
ParticipantIDs | proquest_miscellaneous_1657326099 pubmed_primary_25406241 crossref_citationtrail_10_1161_CIRCGENETICS_113_000485 crossref_primary_10_1161_CIRCGENETICS_113_000485 wolterskluwer_health_01337497-201502000-00013 |
ProviderPackageCode | CITATION AAYXX |
PublicationCentury | 2000 |
PublicationDate | 2015-February |
PublicationDateYYYYMMDD | 2015-02-01 |
PublicationDate_xml | – month: 02 year: 2015 text: 2015-February |
PublicationDecade | 2010 |
PublicationPlace | United States |
PublicationPlace_xml | – name: United States |
PublicationTitle | Circulation. Cardiovascular genetics |
PublicationTitleAlternate | Circ Cardiovasc Genet |
PublicationYear | 2015 |
Publisher | American Heart Association, Inc |
Publisher_xml | – name: American Heart Association, Inc |
References | e_1_3_2_26_2 e_1_3_2_27_2 e_1_3_2_28_2 e_1_3_2_29_2 e_1_3_2_41_2 e_1_3_2_40_2 e_1_3_2_20_2 e_1_3_2_43_2 e_1_3_2_21_2 e_1_3_2_42_2 e_1_3_2_22_2 e_1_3_2_45_2 e_1_3_2_23_2 e_1_3_2_44_2 e_1_3_2_24_2 e_1_3_2_47_2 e_1_3_2_25_2 e_1_3_2_46_2 e_1_3_2_9_2 e_1_3_2_15_2 e_1_3_2_38_2 e_1_3_2_8_2 e_1_3_2_16_2 e_1_3_2_37_2 e_1_3_2_7_2 e_1_3_2_17_2 e_1_3_2_6_2 e_1_3_2_18_2 e_1_3_2_39_2 e_1_3_2_19_2 e_1_3_2_30_2 e_1_3_2_32_2 e_1_3_2_10_2 e_1_3_2_31_2 e_1_3_2_5_2 e_1_3_2_11_2 e_1_3_2_34_2 e_1_3_2_4_2 e_1_3_2_12_2 e_1_3_2_33_2 e_1_3_2_3_2 e_1_3_2_13_2 e_1_3_2_36_2 e_1_3_2_2_2 e_1_3_2_14_2 e_1_3_2_35_2 25691684 - Circ Cardiovasc Genet. 2015 Feb;8(1):4-7. doi: 10.1161/CIRCGENETICS.114.000964. |
References_xml | – ident: e_1_3_2_33_2 doi: 10.1371/journal.pone.0034948 – ident: e_1_3_2_43_2 doi: 10.1016/S0140-6736(03)12384-7 – ident: e_1_3_2_3_2 doi: 10.1038/sj.onc.1202797 – ident: e_1_3_2_26_2 doi: 10.1016/j.cca.2009.02.004 – ident: e_1_3_2_42_2 doi: 10.1161/01.RES.0000233315.38086.bc – ident: e_1_3_2_23_2 – ident: e_1_3_2_44_2 doi: 10.1007/s00125-002-1009-0 – ident: e_1_3_2_15_2 doi: 10.1161/ATVBAHA.110.205492 – ident: e_1_3_2_7_2 doi: 10.1006/excr.1995.1213 – ident: e_1_3_2_30_2 doi: 10.1210/jc.2011-1562 – ident: e_1_3_2_13_2 doi: 10.1093/aje/kwj346 – ident: e_1_3_2_21_2 doi: 10.1016/j.mrfmmm.2011.04.003 – ident: e_1_3_2_31_2 doi: 10.2337/db12-0241 – ident: e_1_3_2_34_2 doi: 10.2337/db13-0744 – ident: e_1_3_2_18_2 doi: 10.1161/HYPERTENSIONAHA.108.123752 – ident: e_1_3_2_38_2 doi: 10.1093/gerona/glp061 – ident: e_1_3_2_2_2 doi: 10.1073/pnas.85.18.6622 – ident: e_1_3_2_35_2 doi: 10.1093/gerona/glq224 – ident: e_1_3_2_45_2 doi: 10.2337/diab.44.4.369 – ident: e_1_3_2_6_2 doi: 10.1371/journal.pone.0019687 – ident: e_1_3_2_40_2 doi: 10.1097/00004647-200102000-00001 – ident: e_1_3_2_39_2 doi: 10.1146/annurev.physiol.010908.163111 – ident: e_1_3_2_10_2 doi: 10.1016/S0140-6736(06)68967-8 – ident: e_1_3_2_29_2 doi: 10.1016/j.atherosclerosis.2009.09.070 – ident: e_1_3_2_24_2 doi: 10.1007/s11010-012-1276-0 – ident: e_1_3_2_28_2 doi: 10.1016/j.atherosclerosis.2009.03.034 – ident: e_1_3_2_4_2 doi: 10.1038/345458a0 – ident: e_1_3_2_11_2 doi: 10.1038/ncomms2602 – ident: e_1_3_2_17_2 doi: 10.1111/ene.12135 – ident: e_1_3_2_20_2 doi: 10.1042/CS20120691 – ident: e_1_3_2_37_2 doi: 10.1111/j.1474-9726.2005.00171.x – ident: e_1_3_2_47_2 doi: 10.1038/ng.2528 – ident: e_1_3_2_5_2 doi: 10.1016/S0014-5793(99)00748-6 – ident: e_1_3_2_19_2 doi: 10.1089/rej.2009.0975 – ident: e_1_3_2_41_2 doi: 10.2174/092986707779313381 – ident: e_1_3_2_25_2 doi: 10.1161/01.ATV.0000067426.96344.32 – ident: e_1_3_2_8_2 doi: 10.1093/epirev/mxs008 – ident: e_1_3_2_12_2 doi: 10.1161/STROKEAHA.111.637207 – ident: e_1_3_2_14_2 doi: 10.1038/jhh.2011.57 – ident: e_1_3_2_32_2 doi: 10.1016/j.trsl.2009.09.012 – ident: e_1_3_2_16_2 doi: 10.1371/journal.pone.0068254 – ident: e_1_3_2_9_2 doi: 10.1001/jama.1979.03290450033020 – ident: e_1_3_2_22_2 doi: 10.1111/j.1474-9726.2009.00470.x – ident: e_1_3_2_36_2 doi: 10.1093/gerona/glq164 – ident: e_1_3_2_27_2 doi: 10.1161/ATVBAHA.111.237271 – ident: e_1_3_2_46_2 doi: 10.1161/ATVBAHA.110.217158 – reference: 25691684 - Circ Cardiovasc Genet. 2015 Feb;8(1):4-7. doi: 10.1161/CIRCGENETICS.114.000964. |
SSID | ssj0064336 |
Score | 2.5377548 |
SecondaryResourceType | review_article |
Snippet | BACKGROUND—Telomeres are repetitive, gene-poor regions that cap the ends of DNA and help maintain chromosomal integrity. Their shortening is caused by... Telomeres are repetitive, gene-poor regions that cap the ends of DNA and help maintain chromosomal integrity. Their shortening is caused by inflammation and... |
SourceID | proquest pubmed crossref wolterskluwer |
SourceType | Aggregation Database Index Database Enrichment Source Publisher |
StartPage | 82 |
SubjectTerms | Aging - metabolism Aging - pathology Cellular Senescence Diabetes Mellitus, Type 2 - metabolism Diabetes Mellitus, Type 2 - pathology Humans Leukocytes - metabolism Leukocytes - pathology Myocardial Infarction - metabolism Myocardial Infarction - pathology Stroke - metabolism Stroke - pathology Telomere - metabolism Telomere Homeostasis |
Title | Association Between Shortened Leukocyte Telomere Length and Cardiometabolic Outcomes: Systematic Review and Meta-Analysis |
URI | https://ovidsp.ovid.com/ovidweb.cgi?T=JS&NEWS=n&CSC=Y&PAGE=fulltext&D=ovft&AN=01337497-201502000-00013 https://www.ncbi.nlm.nih.gov/pubmed/25406241 https://www.proquest.com/docview/1657326099 |
Volume | 8 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1ta9swEBZZB2NjjL0ve0OD7VNwF79J1r6V0NJ2TceaBPrNyPKZlabxSBxG90f2d3eyZMVpOtbtizHCkoXu8enOeu6OkPe8z0ExlntRIrmnHQgvKVTkSVXIEIKEyUwHJw-P2f4kOjyNTzudXy3W0rLKttXPa-NK_keq2IZy1VGy_yBZNyg24D3KF68oYbzeSMattXWEq8U3TZ9F5dmbwvK8VJcV9CqYlhcwh54um9LEstVE1AuoEAU60XW5rHCKhiF3Nb2zYQ3rZz1pk5i0jdrB2VzZKmDbmkHSJrji3HWY5Kp8_YeAD5sDH1tsvHe4Opw6sVXca_aZDn9v_WxFr37qup1JN-bOzLIzR6WOMRu1_2T4cUN-dspXRIGH5qTRx3BNm9XYyQYwjfY1ZYw2NwWmN4XBwclA0wHHB4ORrmRT52k15YLW03Aff0n3JkdH6Xj3dHyL3A7Q_9ClMT5_dcdTaMXVtSfd5CxxEF_08Q-vWTd7NnyZe-T-j1LTIxbndXREy8YZPyQPrHNCdwzSHpEOzB6TO0NLv3hCLluAoxZw1AGOOsDRBnDUAI6ifOgVwNEGcJ_oCm7UwK1-fg1uT8lkb3c82Pds7Q5PhXGiCR0gWC7jTLEgyn2AAneGqEh4rgolChkrkQUihygIhGRBJlRS6HClhIsihFCFz8jWrJzBC0JBoQ-MzWhrZVE_gayI0SwGkSch5zITXcKapU2VTWyv66tM09rBZX7algm2hKmRSZf0XcfvJrfL37u8a2SXoh7Wh2tyBuVykfos5ggFdLi65LkRqhs0QLcIl8HvEm9NyqmJdU7RDQt5JLinv4p-k-zBD1_e4G2vyN3Vt_SabFXzJbxBO7nK3taY_Q1if8B6 |
linkProvider | Colorado Alliance of Research Libraries |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Association+between+shortened+leukocyte+telomere+length+and+cardiometabolic+outcomes%3A+systematic+review+and+meta-analysis&rft.jtitle=Circulation.+Cardiovascular+genetics&rft.au=D%27Mello%2C+Matthew+J+J&rft.au=Ross%2C+Stephanie+A&rft.au=Briel%2C+Matthias&rft.au=Anand%2C+Sonia+S&rft.date=2015-02-01&rft.issn=1942-3268&rft.eissn=1942-3268&rft.volume=8&rft.issue=1&rft.spage=82&rft_id=info:doi/10.1161%2FCIRCGENETICS.113.000485&rft.externalDBID=NO_FULL_TEXT |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1942-325X&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1942-325X&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1942-325X&client=summon |